HYLORIS PHARMACEUTICALS
Hyloris Pharmaceuticals is an innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals. Hyloris Pharmaceuticals develop innovative proprietary products that offer significant advantages compared to currently available alternatives.
HYLORIS PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2013-01-01
Status:
Active
Contact:
+32 (0)4 346 02 07
Total Funding:
30 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Meusinvest (Noshaq)
Meusinvest (Noshaq) investment in Venture Round - Hyloris Pharmaceuticals
Saffelberg Investments
Saffelberg Investments investment in Venture Round - Hyloris Pharmaceuticals
Scorpiaux
Scorpiaux investment in Venture Round - Hyloris Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-06 | Pleco Therapeutics | Hyloris Pharmaceuticals investment in Series A - Pleco Therapeutics | 17.3 M EUR |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-05-26 | Hyloris appoints Patrick Jeanmart as Chief Financial Officer |